The antibody-based pharmaceuticals resource library’s Podcast
By antibodybasedpharmaceuticalsresourcelibrary
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Education
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 3
Reviews: 0
Episodes: 496
Description
Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.
| Episode | Date |
|---|---|
|
Webinar: Generation of a Dual-Function Multi-Engager Antibody for Simultaneous Targeting NK Cells and Tumor Cells
|
May 27, 2025 |
|
Transgenic Mice in Cancer Research
|
Apr 30, 2025 |
|
Webinar: Programmable Molecular Tools for Biology and Genome Editing
|
Apr 18, 2025 |
|
Hybrid Interactions and Hybrid Systems for Brain Repair
|
Mar 27, 2025 |
|
Neuro-robotic Systems Connecting Neurons with Robots
|
Mar 27, 2025 |
|
Closed-Loop Control of In-Vitro Neural Network Dynamics
|
Mar 27, 2025 |
|
A Brief Overview of Closed-Loop Neural Interfaces
|
Mar 27, 2025 |
|
Long-Term Activity Dynamics of Single Neurons and Networks
|
Mar 27, 2025 |
|
Dynamics of Nervous System Activity
|
Mar 27, 2025 |
|
Patents in Immunology: The Rise of Complement Inhibitors
|
Mar 27, 2025 |
|
Visualizing Complement Activation Noninvasively
|
Mar 27, 2025 |
|
From Biomaterials to Blood Reactions: Understanding the Hemocompatibility Puzzle
|
Mar 27, 2025 |
|
Electrophysiological Signal Analysis of Human Stem Cell-Derived Neural Networks
|
Mar 26, 2025 |
|
Applications of Human Stem Cell-Derived Neural Networks
|
Mar 26, 2025 |
|
The Current State of Human Functional Neuron Cultures In Vitro
|
Mar 26, 2025 |
|
Cytoprotective Mirococept: Benefits, Risks, and Alternatives in Renal Transplants
|
Mar 26, 2025 |
|
Therapeutic Targets and Membrane Regulators in Kidney Transplants
|
Mar 25, 2025 |
|
Chronic Rejection Driven by Complement-Mediated Microvascular Damage II
|
Mar 25, 2025 |
|
Chronic Rejection Driven by Complement-Mediated Microvascular Damage I
|
Mar 25, 2025 |
|
Homeostatic Plasticity and Lifelong Synaptic Organization
|
Mar 22, 2025 |
|
Neural Competition and Visual Experience in Ocular Dominance and Synaptic Organization
|
Mar 22, 2025 |
|
Exploring Synapse Elimination, Reorganization, and Retinal Activity in the Vertebrate Visual System
|
Mar 21, 2025 |
|
Wnt Pathways and Glial Cells in Synaptogenesis at Excitatory and Inhibitory Synapses
|
Mar 21, 2025 |
|
Regulation of Synaptic Formation EphEphrin and Wnt Signaling in the CNS
|
Mar 20, 2025 |
|
BDNF and EphEphrin Signaling in Synaptic Development
|
Mar 20, 2025 |
|
Reciprocal Signaling and the Role of Motile Dendritic Spines in Synaptic Development
|
Mar 19, 2025 |
|
Cell Adhesion Molecules, Neurexins, and Neuroligins in Synaptic Stabilization
|
Mar 18, 2025 |
|
Similarities in Synaptic Elements and the Role of Postsynaptic Density
|
Mar 18, 2025 |
|
Models of Synaptic Elimination in the Neuromuscular Junction
|
Mar 13, 2025 |
|
Synaptic Basal Lamina and Laminins in Presynaptic Development
|
Mar 13, 2025 |
|
Screening Compounds for Developmental Neurotoxicity Using MEA
|
Feb 28, 2025 |
|
Data Analysis and Applications of MEA in Acute Neurotoxicity Screening
|
Feb 28, 2025 |
|
Perisynaptic Schwann Cells in Neuromuscular Junction Formation and Acetylcholine Receptor Subunit Synthesis
|
Feb 27, 2025 |
|
MuSK, LRP4, and Rapsyn Mediate Agrin Signaling and AChR-Cytoskeleton Linkage
|
Feb 27, 2025 |
|
Considerations for Testing Neurotoxicity Using MEA
|
Feb 27, 2025 |
|
Research on Active High-Density MEA in In Vitro Brain Disease Models
|
Feb 27, 2025 |
|
Revised Agrin Hypothesis Synaptic Basal Lamina and ACh Receptor Clustering
|
Feb 26, 2025 |
|
Development and Organization of the Neuromuscular Junction
|
Feb 26, 2025 |
|
Research on Network Electrophysiology of Active High-Density MEA
|
Feb 26, 2025 |
|
Active High-Density MEA and its Neural Electronic Interface Principles
|
Feb 26, 2025 |
|
Open-Source Tools for Processing and Analyzing Extracellular Neuronal Signals In Vitro
|
Feb 25, 2025 |
|
Reconstructing Functional Connectivity from MEA Records and Calcium Imaging
|
Feb 25, 2025 |
|
Chemical Synapse Development in the Peripheral and Central Nervous Systems
|
Feb 25, 2025 |
|
p75NTR and Precursor Forms of Neurotrophins Help Mediate Neuronal Death During Development
|
Feb 25, 2025 |
|
Programmed Cell Death During Neural Development
|
Feb 24, 2025 |
|
The significance of using MEA or calcium imaging to infer the connectivity of cultured neuronal networks
|
Feb 24, 2025 |
|
Methods for Detecting Neuronal Bursts
|
Feb 22, 2025 |
|
The Physiological Significance of Neuronal Bursts
|
Feb 21, 2025 |
|
Common Methods for Neuronal Spike Sorting and Quality Assessment
|
Feb 21, 2025 |
|
Trk Receptor Interactions and Growth Factor Signaling in Neuronal Survival and Outgrowth
|
Feb 21, 2025 |
|
Neurotrophin Signaling and Trk Receptor Function in Cell Survival and Transport
|
Feb 21, 2025 |
|
Neuronal Spike Sorting and Detection
|
Feb 13, 2025 |
|
From MEA to MOA The Next Generation of Bioelectronic Interfaces for Neuron Cultures
|
Feb 13, 2025 |
|
Discovery and Identification of Nerve Growth Factor and Related Neurotrophic Proteins
|
Feb 13, 2025 |
|
Nerve Cell Development Insights from Tissue Size, Tumors, and In Vitro Studies
|
Jan 24, 2025 |
|
Advances in Retinal Axon Guidance Chemoaffinity, Eph-Ephrin, and Self-Avoidance
|
Jan 24, 2025 |
|
Intracellular Recordings Using MEA Based on Vertical Nanoelectrodes
|
Jan 24, 2025 |
|
Exploring the World of MEA Based on Vertical Nanoelectrodes
|
Jan 24, 2025 |
|
The Retinotectal System and the Chemotopy Hypothesis
|
Jan 22, 2025 |
|
Regulatory Mechanisms of Commissural Axon Growth in Vertebrates
|
Jan 22, 2025 |
|
Applications of HD-MEA
|
Jan 22, 2025 |
|
Factors Affecting HD-MEA Performance
|
Jan 22, 2025 |
|
Guidance Mechanisms for Commissural Axons Attraction and Repulsion at the Midline
|
Jan 21, 2025 |
|
Guidance Mechanisms in Vertebrate Motor Neuron Development
|
Jan 21, 2025 |
|
The Classification and Development of Microelectrode Arrays
|
Jan 21, 2025 |
|
Biocompatible Scaffolds for In Vitro Neuronal Cultures
|
Jan 21, 2025 |
|
Enhancing HSPC Homing Mechanisms of Distal CC Activation
|
Jan 21, 2025 |
|
Enhancing Hematopoietic Transplantation Pro-Homing Mechanisms via Proximal CC Pathways
|
Jan 18, 2025 |
|
The Role of the Complement System in Skeletal Muscle Physiology and Pathology
|
Jan 17, 2025 |
|
Growth Cone Substrate Preferences In Vitro and In Vivo
|
Jan 16, 2025 |
|
Modeling the Blood-Brain Barrier In Vitro Delivering Drugs to the CNS with Graphene Nanosheets
|
Jan 16, 2025 |
|
The Role of Complement Activation in Cardiac Muscle
|
Jan 16, 2025 |
|
Complement-Targeted Treatments for Periodontitis
|
Jan 16, 2025 |
|
Growth Cone Motility and Pathfinding
|
Jan 09, 2025 |
|
The Interaction between Graphene and the Central Nervous System
|
Jan 07, 2025 |
|
CFHR5 Nephropathy_C3 Glomerulonephritis Clinical and Molecular Insights
|
Jan 07, 2025 |
|
Poxviruses Outbreak Cases in the Middle East
|
Jan 04, 2025 |
|
The Poxvirus and Its Major Pathogenic Species
|
Jan 04, 2025 |
|
The One Health Concept Integrating Human, Animal, and Environmental
|
Jan 04, 2025 |
|
Future Prevention and Control Measures for Monkeypox
|
Jan 04, 2025 |
|
Monkeypox Transmission and Its Comparison to SARS-CoV-2
|
Jan 04, 2025 |
|
Monkeypox Understanding the Concept and Its Historical Evolution
|
Jan 04, 2025 |
|
The Functions of FHL1 and Factor H in Age-Related Macular Degeneration
|
Dec 30, 2024 |
|
Development of Specialized Sensory Cells
|
Dec 30, 2024 |
|
Development of the Inner Ear and Retina in Vertebrates
|
Dec 30, 2024 |
|
From Factor H and FHL1 Unraveling the Role of Complement Regulators in Disease
|
Dec 30, 2024 |
|
New Perspectives on Paroxysmal Nocturnal Hemoglobinuria and Complement Pathway Innovations
|
Dec 27, 2024 |
|
Development of Specialized Sensory Cells
|
Dec 27, 2024 |
|
Membrane-Bound Complement Regulatory Proteins Novel Biomarkers and Therapeutic Targets in SLE
|
Dec 26, 2024 |
|
MASPs Key Players in Complement Activation
|
Dec 25, 2024 |
|
Alzheime's and Other Memory Disorders
|
Dec 25, 2024 |
|
The Science and Treatment of Epilepsy
|
Dec 24, 2024 |
|
How Are Protease Inhibitors Shaping the Future of Medicine
|
Dec 24, 2024 |
|
The Role of Neuregulin in the Determination of Myelinating Schwann Cells in the Peripheral Nervous System
|
Dec 24, 2024 |
|
Secrets of Brain Blood Flow Understanding Cerebrovascular Disorders
|
Dec 23, 2024 |
|
What Keeps Our Enzymes in Check
|
Dec 21, 2024 |
|
Exploring the Brain Cutting-Edge In Vitro Models
|
Dec 19, 2024 |
|
Determination and Differentiation of Neural Crest-Derived Neurons
|
Dec 19, 2024 |
|
How Do Proteases and the Complement System Keep Us Healthy
|
Dec 17, 2024 |
|
Cutting-Edge Technologies for Monitoring and Manipulating Brain Activity
|
Dec 17, 2024 |
|
Exploring the Mechanisms of Fate Determination in Vertebrate Central Nervous System Neurons
|
Dec 16, 2024 |
|
Trends in Modeling with Human Stem Cell Technology in Neuroscience
|
Dec 13, 2024 |
|
Lateral Inhibition and Notch Receptor Signaling
|
Dec 12, 2024 |
|
The Evolution of Neuron Cell Culture From History to Modern Technological Leaps
|
Dec 11, 2024 |
|
Migration in the Peripheral Nervous System Examples from Neural Crest Cells
|
Dec 10, 2024 |
|
Migration Patterns of Neurons
|
Dec 10, 2024 |
|
Mechanisms of Neuronal Migration
|
Dec 09, 2024 |
|
Cellular Migration in the Central Nervous System
|
Dec 07, 2024 |
|
The Process of Generating Neurons and Glial Cells
|
Dec 06, 2024 |
|
How Dorsal Ventral Patterning Works in the Front of the Neural Tube
|
Dec 05, 2024 |
|
Precision Targeting of Complement Drugs
|
Dec 05, 2024 |
|
A Toolkit for Complement Inhibition
|
Dec 04, 2024 |
|
Regulatory Signaling Pathways in Dorsal Neuron Development
|
Dec 04, 2024 |
|
Uncovering Complement's Weakness, One Disease at a Time
|
Dec 02, 2024 |
|
Dorsal Patterning in the Posterior Neural Tube
|
Dec 02, 2024 |
|
Evolving Ideas and Horizons in Complement Research
|
Nov 25, 2024 |
|
Ventral Signals and Motor Neuron Patterning in the Posterior Neural Tube
|
Nov 25, 2024 |
|
Anatomical Landmarks and Signaling Centers in the Posterior Vertebrate Neural Tube
|
Nov 25, 2024 |
|
How are Retinoic Acid Levels Controlled
|
Nov 20, 2024 |
|
HOX Genes Play a Crucial Role in Regulating Hindbrain Segmentation
|
Nov 20, 2024 |
|
Rhombomeres the Building Blocks of the Hindbrain
|
Nov 19, 2024 |
|
Regional Division of Forebrain, Midbrain, and Hindbrain Regions
|
Nov 19, 2024 |
|
The Formation of the Neural Tube
|
Nov 13, 2024 |
|
Noggin, Follistatin, and Chordin Inhibit Epidermal Induction
|
Nov 13, 2024 |
|
Initiation and Development of Neural Induction
|
Nov 11, 2024 |
|
Neural Tissue Designation during Embryogenesis
|
Nov 11, 2024 |
|
Gene Regulation during Nervous System Development
|
Nov 09, 2024 |
|
Origin and Development of the Nervous System
|
Nov 06, 2024 |
|
Introduction to Developmental Neurobiology Field
|
Oct 12, 2024 |
|
Oncolytic Viruses: Research Progress in Anti-Cancer Weapons
|
Sep 11, 2024 |
|
Targeted Oncolytic Viruses: New Hope in Cancer Treatment
|
Sep 11, 2024 |
|
Adeno-Associated Viruses: The Future of Gene Therapy
|
Sep 11, 2024 |
|
Adenoviruses: The Key Players in Gene Therapy
|
Sep 11, 2024 |
|
From Enemy to Ally: The Application of Retroviruses in Gene Therapy
|
Sep 11, 2024 |
|
Gene Therapy: A Revolutionary Breakthrough in Viral Technology
|
Sep 11, 2024 |
|
Unveiling the New Coronavirus: A Global Health Challenge
|
Aug 23, 2024 |
|
The Ever-Evolving Influenza: Understanding the Chameleon of Viruses
|
Aug 23, 2024 |
|
From Bats to Humans: Understanding the Viral Bridge
|
Aug 23, 2024 |
|
Why Are New Viruses Emerging? The Scientific Truth Behind the Phenomenon
|
Aug 23, 2024 |
|
Unveiling the Mystery of a New Virus: What We Need to Know
|
Aug 23, 2024 |
|
Unlocking the Immune Arsenal: A Guide to Different Vaccines
|
Aug 01, 2024 |
|
From cowpox to mRNA: the century-long journey of viral vaccines
|
Aug 01, 2024 |
|
The Evolution of Vaccines: Triumphs and Challenges
|
Aug 01, 2024 |
|
HERVs: The Invisible Threat in the Human Genome
|
Aug 01, 2024 |
|
HERVs: From Genomic Junk to Immune Modulators
|
Aug 01, 2024 |
|
Hidden Viruses in Our Genes: How HERVs Influence Brain Development and Function?
|
Aug 01, 2024 |
|
HERVs: Decoding the ‘Black Box’ of Placental Development
|
Aug 01, 2024 |
|
Human Endogenous Retroviruses: A 250-Million-Year Story
|
Aug 01, 2024 |
|
Viral Codes in Human Genes
|
Aug 01, 2024 |
|
Viruses in Disguise How HPV and MCPyV Cause Cancer
|
Jul 25, 2024 |
|
Hepatitis and Liver Cancer: The Hidden Connection
|
Jul 25, 2024 |
|
Beyond the Blisters: How Herpesviruses Can Cause Cancer
|
Jul 25, 2024 |
|
Human retrovirus finally appears
|
Jul 25, 2024 |
|
Secrets of oncogenes: How retroviruses alter cell fate-Ⅱ
|
Jul 25, 2024 |
|
Secrets of oncogenes: How retroviruses alter cell fate-Ⅰ
|
Jul 25, 2024 |
|
Viruses and cancer: A deadly microbial conspiracy
|
Jul 25, 2024 |
|
P53: The Guardian of the Genome
|
Jul 25, 2024 |
|
Is SV40 a human tumor virus?
|
Jul 25, 2024 |
|
SV40: The Hidden Virus in Vaccines
|
Jul 25, 2024 |
|
The Road to Ending AIDS: Global Progress and Challenges in HIV Prevention-Ⅱ
|
Jul 25, 2024 |
|
The Road to Ending AIDS: Global Progress and Challenges in HIV Prevention-Ⅰ
|
Jul 25, 2024 |
|
Viruses, Change, and Human Evolution: The Story of Polio-Ⅱ
|
Jul 25, 2024 |
|
Viruses, Change, and Human Evolution: The Story of Polio-Ⅰ
|
Jul 25, 2024 |
|
The Smallpox Chronicles: How Humanity Triumphed Over Its Deadliest Foe-Ⅱ
|
Jul 25, 2024 |
|
The Smallpox Chronicles: How Humanity Triumphed Over Its Deadliest Foe-Ⅰ
|
Jul 25, 2024 |
|
Mechanisms and Applications of Antiviral Neutralizing Antibodies
|
Jun 15, 2024 |
|
The Role of Adaptive Immunity in Global Health
|
Jun 15, 2024 |
|
The Invisible Shield-How Innate Immunity Protects Against Viruses
|
Jun 15, 2024 |
|
Fighting the Virus-Uncovering the Power of Built-in Immunity
|
Jun 15, 2024 |
|
Hidden Diseases: Mysteries and Challenges of Latent Viral Diseases
|
May 22, 2024 |
|
Hepatitis C: A Chronic Challenge and The Future of Global Health
|
May 22, 2024 |
|
Shadow of Acute: Influenza Viruses and Human Health’s Urgent Showdown
|
May 22, 2024 |
|
Entwined Existence: The Co-evolutionary Dance of Viruses and Cells
|
May 21, 2024 |
|
The Quest to Uncover Viral Ancestry
|
May 21, 2024 |
|
Panorama of virus functions: Microscopic forces from invasion to control
|
May 21, 2024 |
|
The life of a virus: a story from invasion to replication
|
May 21, 2024 |
|
Map of the virus world: Decoding the mystery of classification
|
May 21, 2024 |
|
The Profound Impact of the Virus on Individuals and Society
|
May 21, 2024 |
|
Advances in Oncolytic Virotherapy
|
Mar 09, 2024 |
|
The Beneficial Effect of Microvesicles on Regeneration Is Comparable to That of Parental Cells
|
Mar 04, 2024 |
|
How Does the Treatment of Damaged Organs in Regenerative Medicine Relate to Microvesicles
|
Mar 04, 2024 |
|
The role and application of exosomes in tumor metastasis
|
Mar 04, 2024 |
|
How do tumor exosomes affect the behavior of endothelial cells and bone marrow-derived cells during metastasis
|
Mar 04, 2024 |
|
Lipid Nanoparticle-based mRNA Vaccine
|
Feb 26, 2024 |
|
How do tumor exosomes regulate fibroblast behavior during metastasis
|
Feb 07, 2024 |
|
What is the role of tumor exosomes in establishing metastasis niches
|
Feb 07, 2024 |
|
The Role of Transposon Horizontal Transfer in Microvesicles in Cancer
|
Feb 07, 2024 |
|
How do tumor microvesicles mediate horizontal gene transfer
|
Feb 07, 2024 |
|
Ribosome Analysis - Creative Biolabs
|
Jan 17, 2024 |
|
Immunosuppressive Properties of Tumor-derived Exosomes and Their Clinical Significance
|
Dec 29, 2023 |
|
Immune Properties of Tumor-derived Exosomes
|
Dec 29, 2023 |
|
Why are Tumor-derived Exosomes Involved in Immune Regulation
|
Dec 29, 2023 |
|
How do Circulating Cell-derived Exosomes Participate in Immune Regulation
|
Dec 29, 2023 |
|
Exosomes Are Key to Cell-to-Cell Communication
|
Nov 30, 2023 |
|
Composition And Formation of Circulating Cell-Derived Exosomes
|
Nov 30, 2023 |
|
How to Define or Subdivide Exosomes
|
Nov 30, 2023 |
|
What are the Uses of Exosomes for Various Aspects of Tumor Therapy
|
Nov 30, 2023 |
|
Advances in CAR-T Cell Therapy
|
Oct 30, 2023 |
|
Liver Stem Cells
|
Oct 18, 2023 |
|
The Establishment of Additional Cell Lineages During Kidney Development
|
Oct 18, 2023 |
|
Genes that Control Early Kidney Development
|
Oct 18, 2023 |
|
The Anatomy of Kidney Development
|
Oct 18, 2023 |
|
Endothelial Cell Diversification-Ⅱ
|
Oct 18, 2023 |
|
Endothelial Cell Differentiation-Ⅰ
|
Oct 18, 2023 |
|
Cultures for Embryonic Stem Cell Differentiation
|
Oct 18, 2023 |
|
The Ever-evolving Regeneration Concepts
|
Oct 18, 2023 |
|
Cardiac Stem Cell
|
Oct 18, 2023 |
|
Multiple Connections Between Tumor-Derived Exosomes and Tumors
|
Oct 16, 2023 |
|
What Are the Effects of Exosomes on Tumor Progression Other Than Immunity
|
Oct 16, 2023 |
|
Exosomes, Immune Regulation and Tumor Lesions
|
Oct 16, 2023 |
|
The Contribution of Tetraspanins and Exosomes in Tumor Metastasis
|
Oct 16, 2023 |
|
Intrinsic Regulation of Satellite Cells
|
Sep 18, 2023 |
|
Heterogeneity and Self-renewal of Satellite Cells
|
Sep 18, 2023 |
|
Satellite Cells Identification
|
Sep 18, 2023 |
|
Skeletal and Non-Skeletal Tissue Regeneration by Mesenchymal Stem Cells
|
Sep 18, 2023 |
|
Mesenchymal Stem Cells
|
Sep 18, 2023 |
|
Human Embryonic Stem Cells as a Source for Vascular Progenitors
|
Sep 18, 2023 |
|
Human Vascular Development, Maintenance, and Renewal
|
Sep 18, 2023 |
|
Cell Differentiation in the Skeleton
|
Sep 18, 2023 |
|
Red Blood Cells or Erythrocytes
|
Sep 18, 2023 |
|
Factors That Promote Hematopoiesis
|
Sep 18, 2023 |
|
Hematopoietic Stem Cells in Embryos and Embryoid Bodies
|
Sep 18, 2023 |
|
The Relationship Between Tetraspanins, Exosomes, Angiogenesis, And Hemostasis
|
Sep 18, 2023 |
|
What Should We Know about Exosomal Tetraspanins in Fusion?
|
Sep 18, 2023 |
|
Functional Activity of Exosomal Tetraspanins in The Modulation of Immune Responses
|
Sep 18, 2023 |
|
How Does Tetraspanins Affect the Vesicle Transport of Exosomes?
|
Sep 18, 2023 |
|
Basic Information of Tetraspanins in Exosomes
|
Sep 18, 2023 |
|
Exosomes Help Lipids To Be Localized Correctly
|
Sep 18, 2023 |
|
What Functional Effects Will the Transfer of Exosomal Lipids Between Cells Cause?
|
Sep 18, 2023 |
|
Can exosomes also participate in lipid metabolism?
|
Sep 18, 2023 |
|
What lipids do exosomes consist of?
|
Sep 18, 2023 |
|
Sites of Initiation of Primitive and Definitive Hematopoiesis and Vasculogenesis-Part II
|
Aug 28, 2023 |
|
Sites of Initiation of Primitive and Definitive Hematopoiesis and Vasculogenesis-Part I
|
Aug 28, 2023 |
|
Putative Stem Cell Markers and Cell Signaling in Multipotent Epithelial Skin Stem Cells
|
Aug 28, 2023 |
|
Models of Epithelial Stem Cell Activation
|
Aug 28, 2023 |
|
The Bulge as a Residence of Epithelial Skin Stem Cells
|
Aug 28, 2023 |
|
Introduction to Mouse Skin Organization
|
Aug 28, 2023 |
|
Stem Cells in the Auditory Organ
|
Aug 28, 2023 |
|
Growth of Retinal Neurospheres from the Ciliary Margin of Mammals
|
Aug 28, 2023 |
|
In Vivo Retinal Neurogenesis in the Post-hatch Chicken
|
Aug 28, 2023 |
|
The Optic Vesicle Generates Diverse Cell Types that can Undergo Transdifferentiation
|
Aug 28, 2023 |
|
Review Of Other Important Delivery Systems
|
Aug 28, 2023 |
|
Advantages And Disadvantages of Cationic Liposome Delivery of Genetic Material
|
Aug 28, 2023 |
|
Liposomes Appear to Be the Most Promising Delivery Vehicle for Ribozyme Delive
|
Aug 28, 2023 |
|
Application Of Cationic Liposomes in Oligonucleotide Delivery
|
Aug 28, 2023 |
|
An Overview of Studies on Delivery of Antisense Oligonucleotides by Anionic or
|
Aug 28, 2023 |
|
Delivery Systems for Antisense Oligonucleotides
|
Aug 28, 2023 |
|
Deep Dive into The Antisense Oligonucleotides
|
Aug 28, 2023 |
|
Basic Understanding of Antisense Oligonucleotides
|
Aug 28, 2023 |
|
Factors That Determine Transfection Efficiency
|
Aug 28, 2023 |
|
What Is the Mechanism Of In Vivo Transfection
|
Aug 28, 2023 |
|
What Is the Mechanism Of In Vitro Transfection
|
Aug 28, 2023 |
|
Why Do We Need to Understand the Mechanism of Transfection
|
Aug 28, 2023 |
|
Discussion On Structure-Activity Relationship Research at The Colloid Level
|
Aug 28, 2023 |
|
What Colloidal Genosomes Are Effective
|
Aug 28, 2023 |
|
What role do lipid molecules play in exosome mediated intercellular communication
|
Jul 28, 2023 |
|
Advantages Of Exosomes in The Diagnosis and Treatment of Diseases
|
Jul 28, 2023 |
|
What are the biological functions of exosomal shuttle RNA
|
Jul 28, 2023 |
|
Why is the loading of RNA in exosomes specific
|
Jul 28, 2023 |
|
What should we learn about exosomal shuttle RNA
|
Jul 28, 2023 |
|
Adult Neurogenesis In Vivo
|
Jul 28, 2023 |
|
Glial Characteristics of Neural Stem Cells
|
Jul 28, 2023 |
|
Regulation of Proneural Activity and Neurogenesis
|
Jul 28, 2023 |
|
Neural Patterning
|
Jul 28, 2023 |
|
How Neural Progenitors First Arise During Embryonic Development
|
Jul 28, 2023 |
|
Stem and Progenitor Cells Isolated from Cord Blood
|
Jul 28, 2023 |
|
Amniotic Fluid Stem Cells
|
Jun 29, 2023 |
|
Amniotic Fluid Mesenchymal Stem Cells
|
Jun 29, 2023 |
|
Migration of Primordial Germ Cells
|
Jun 29, 2023 |
|
Origin of the Germ Cell Lineage
|
Jun 29, 2023 |
|
Results Of Research On Diacyl Chain Cationic Lipids
|
Jun 28, 2023 |
|
Results Of Research On Cholesterol-anchored Cationic Lipids
|
Jun 28, 2023 |
|
Why Study The Structure-activity Relationship Of The Genosome
|
Jun 28, 2023 |
|
Summary Of Findings Across Multiple Routes Of Administration
|
Jun 28, 2023 |
|
What Should We Know About Pulmonary Delivery Of Genosomes
|
Jun 28, 2023 |
|
Stable Genosomes And Related Mechanisms
|
Jun 28, 2023 |
|
Limitations of Naked DNA Administration In Vivo
|
Jun 28, 2023 |
|
Difficulties In Transfection And Expression Of Genosomes In Vivo
|
Jun 28, 2023 |
|
Optimization Of Liposomes For In Vitro Transfection
|
Jun 28, 2023 |
|
In Vitro Expression Of DNA-liposome Complexes
|
Jun 28, 2023 |
|
Ep.15 Dendritic Cells in Clinical Hematopoietic Cell Transplantation
|
May 15, 2023 |
|
Ep.14 Human Dendritic Cells
|
May 15, 2023 |
|
Ep.13 Natural Killer Cell Dysfunction in Cancer Therapies
|
May 15, 2023 |
|
Ep.12 Adoptive NK Cell Therapies
|
May 15, 2023 |
|
Ep.11 Biology and Function of Natural Killer Cells
|
May 15, 2023 |
|
Ep.10 Effects of Regulatory T Cells on Tumor Immunity and the Clinical Application
|
Apr 07, 2023 |
|
Ep.9 Mechanism of Immunosuppression by Regulatory T Cells
|
Apr 07, 2023 |
|
Ep.8 Characterization And Functional Abilities of Regulatory T Cells
|
Apr 07, 2023 |
|
Vaccine for Cancer Immunotherapy
|
Mar 06, 2023 |
|
PROTAC Technology in Tumor Targeted Therapy
|
Mar 02, 2023 |
|
Macrophages as Targets in Cancer Immunotherapy
|
Jan 31, 2023 |
|
Does the Genosome Produce Toxicity in Vivo
|
Jan 13, 2023 |
|
Pharmacokinetics of DNA-liposome Complexes
|
Jan 13, 2023 |
|
How to Characterize the Genosomes
|
Jan 13, 2023 |
|
Information on the Structure of DNA-cationic Liposome Complexes
|
Jan 13, 2023 |
|
What Theory is Involved in the Interaction of DNA and Liposomes
|
Jan 13, 2023 |
|
The Human Embryo and Other Related Highlights
|
Dec 29, 2022 |
|
From Implantation to Gastrulation
|
Dec 29, 2022 |
|
The Pre-Implantation Development of Mammalian Embryos
|
Dec 29, 2022 |
|
How Could A Cell’s Phenotype Be Changed
|
Dec 29, 2022 |
|
Metaplasia And Transdifferentiation
|
Dec 29, 2022 |
|
Stem Cells And Cell Fusion
|
Dec 29, 2022 |
|
Ep.7 Advances in Broadening the Repertoire of Available Donor Sources
|
Dec 29, 2022 |
|
Ep.6 Advances In the Generation of Epstein-Barr Virus-Specific and Multi-Virus-Specific T cells
|
Dec 29, 2022 |
|
Ep.5 Advances In the Generation of Cytomegalovirus-Specific T Cells
|
Dec 29, 2022 |
|
Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue
|
Dec 22, 2022 |
|
Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation
|
Dec 22, 2022 |
|
A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death
|
Dec 22, 2022 |
|
Tumor TargetingIntroduction of Oncolytic Adenovirus and the Three Retargeting Strategies
|
Dec 22, 2022 |
|
The Method to Get Soluble Coxsackie and Adenovirus Receptor Bispecific Adapter Proteins
|
Dec 22, 2022 |
|
Immunomodulation in Oncolytic Measles Virotherapy-Ⅲ
|
Dec 22, 2022 |
|
Immunomodulation in Oncolytic Measles Virotherapy-Ⅱ
|
Dec 22, 2022 |
|
Immunomodulation in Oncolytic Measles Virotherapy-Ⅰ
|
Dec 22, 2022 |
|
Ep.4 Multiple Aspects of T Cell Receptors-Gene-Modified T Cells for Cancer
|
Dec 21, 2022 |
|
Ep.3 CAR-T Cells for Leukemias in Adults
|
Dec 21, 2022 |
|
Ep.2 CAR-T Cells for Leukemias in Children
|
Dec 21, 2022 |
|
Ep.1 Multiple Aspects of Chimeric Antigen Receptor T Cells
|
Dec 21, 2022 |
|
Monkeypox Drug and Vaccine Discovery
|
Dec 05, 2022 |
|
AI-augmented Drug Discovery
|
Dec 01, 2022 |
|
Basic Information About DNA-liposome Complexes
|
Nov 03, 2022 |
|
Various Applications of Liposomes
|
Nov 03, 2022 |
|
The Interaction Between Liposomes and Cells and The Toxicity of Cationic Liposomes
|
Nov 03, 2022 |
|
How To Characterize the Quality of Liposomes
|
Nov 03, 2022 |
|
What Affects the Stability of Liposomes
|
Nov 03, 2022 |
|
What are the Methods Used to Prepare Liposomes
|
Nov 03, 2022 |
|
Preliminary Understanding of Cationic Liposomes
|
Nov 03, 2022 |
|
What Should We Know About Liposomes
|
Nov 03, 2022 |
|
Novel Treatment of Leukemia
|
Nov 03, 2022 |
|
Graft-Versus-Leukemia Effect in ASCT
|
Nov 03, 2022 |
|
Complications After Allogeneic Stem Cell Transplantation
|
Nov 03, 2022 |
|
The Endosomes and Self-Tolerance
|
Nov 03, 2022 |
|
Breaking Immune Tolerance to Tumors
|
Nov 03, 2022 |
|
Autoimmunity and T cell activation
|
Nov 03, 2022 |
|
How To Make Transiently Redirected T Cells
|
Nov 03, 2022 |
|
Chance and Challenge in Tumor Immunotherapy
|
Nov 03, 2022 |
|
What Are the Related Technologies of T Cell Gene Transfer
|
Nov 02, 2022 |
|
T Cell-Based Immunotherapy for Tumor
|
Oct 31, 2022 |
|
Webinar: A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19
|
Oct 27, 2022 |
|
Oligonucleotide-based Therapeutics
|
Oct 21, 2022 |
|
Webinar-Development of Gene Therapy for Genetic Hearing Loss
|
Oct 21, 2022 |
|
Webinar-Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington’s Disease Therapies
|
Oct 21, 2022 |
|
The Injection Time and Dosage of the Dendritic Cell Vaccine
|
Oct 19, 2022 |
|
The Route of Administration of Messenger RNA Loaded Dendritic Cells
|
Oct 19, 2022 |
|
How to Control the Quality of Dendritic Cells and Messenger RNA?
|
Oct 19, 2022 |
|
How to Induce the Maturation of Dendritic Cells In Vitro?
|
Oct 19, 2022 |
|
In What Ways Do Dendritic Cells Carry Messenger RNA
|
Oct 19, 2022 |
|
How To Choose the Right Antigens?
|
Oct 19, 2022 |
|
What Antigens Can Be Loaded on Dendritic Cells?
|
Oct 19, 2022 |
|
Which Cells Play a Key Role in Immunotherapy?
|
Oct 19, 2022 |
|
The Application of Aptamers in Cancer Study
|
Oct 19, 2022 |
|
Design and Application of Ribozyme
|
Oct 19, 2022 |
|
How to Use Ribozyme to Treat Cancer?
|
Oct 19, 2022 |
|
How to Determine the Cellular Localization of Specific MicroRNAs?
|
Oct 19, 2022 |
|
How to Finish Detection and Quantitative Analysis of Small RNAs?
|
Oct 19, 2022 |
|
How to Predict and Validate the Target Genes?
|
Oct 19, 2022 |
|
How to Get a Lot of MicroRNA Probes?
|
Oct 19, 2022 |
|
What Method Can Global Gene Expression Profiling of Multiple Cell Types?
|
Oct 19, 2022 |
|
Can the Inhibitory Effect of Small interfering RNA on the MicroRNA Pathway Be Lifted?
|
Oct 19, 2022 |
|
What Effect Does MicroRNA Have on The Development of Zebrafish?
|
Oct 19, 2022 |
|
What is the Relationship Between MicroRNA Pathway and RNA Interference?
|
Oct 19, 2022 |
|
What is the New Progress of MicroRNA in Gene Therapy?
|
Oct 19, 2022 |
|
Mature MicroRNAs Trigger RNA Interference-Like Gene Silencing in Zebrafish, Chicken and Mice
|
Oct 19, 2022 |
|
What is Man-Made Intronic MicroRNA?
|
Oct 19, 2022 |
|
Intronic MicroRNA And Diseases
|
Oct 19, 2022 |
|
How Does Intronic MicroRNA Come into Being?
|
Oct 19, 2022 |
|
The Past and Present of MicroRNA
|
Oct 19, 2022 |
|
What is Transfected Cell Microarray?
|
Oct 19, 2022 |
|
What is the Relationship Between Long Hairpin RNA and Human Immunodeficiency Virus?
|
Oct 19, 2022 |
|
What are the Special Functions of Small Hairpin RNA?
|
Oct 19, 2022 |
|
The Process of Short Hairpin RNA-Encoding Vector Entering Cells
|
Oct 19, 2022 |
|
How to Identify Efficient small interfering RNA Sequences？
|
Oct 19, 2022 |
|
What Else Targeted Delivery Technologies of Small Interfering RNA?
|
Oct 19, 2022 |
|
Which Strategy Can Enhance siRNA Target Delivery?
|
Oct 19, 2022 |
|
Targeting Small Interfering RNA to Tumor Cells by Peptides
|
Oct 19, 2022 |
|
How to Target Small Interfering RNA by Antibody？
|
Oct 19, 2022 |
|
How to Efficiently Deliver Small Interfering RNA into Living Cells？
|
Oct 19, 2022 |
|
Progress in siRNA Delivery Using Multifunctional Nanoparticles-Ⅳ
|
Oct 19, 2022 |
|
Progress in siRNA Delivery Using Multifunctional Nanoparticles-Ⅲ
|
Oct 19, 2022 |
|
Progress and Contribution of RNA Modification
|
Oct 19, 2022 |
|
Why Dose Ribosomal RNA Modification Matter
|
Oct 19, 2022 |
|
Spliceosomal Small Nuclear RNA Modifications Might Affect Precursor Messenger RNA Splicing
|
Oct 19, 2022 |
|
Mathematical Modeling of Oncolytic Virotherapy
|
Oct 19, 2022 |
|
Fluorescence In Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-Treated Human Brain Tumors
|
Oct 19, 2022 |
|
Considerations for Clinical Translation of MG1 Maraba Virus-Ⅲ
|
Oct 19, 2022 |
|
Considerations for Clinical Translation of MG1 Maraba Virus-Ⅱ
|
Oct 19, 2022 |
|
Considerations for Clinical Translation of MG1 Maraba Virus-Ⅰ
|
Oct 19, 2022 |
|
Generating Primary Models of Human Cancer to Aid in the Development of Clinically Relevant Oncolytic Viruses
|
Oct 19, 2022 |
|
Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus Activity
|
Oct 19, 2022 |
|
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus
|
Oct 19, 2022 |
|
In Vivo Bioimaging for Monitoring Intratumoral Virus Activity
|
Oct 19, 2022 |
|
Delivery of Oncolytic Reovirus by Cell Carriers
|
Oct 19, 2022 |
|
Evaluation of Oncolytic Virus-Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models
|
Oct 19, 2022 |
|
Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination
|
Oct 19, 2022 |
|
Immunohistochemistry for Tumor-Infiltrating Immune Cells After Oncolytic Virotherapy
|
Oct 19, 2022 |
|
Application of New Probiotics
|
Oct 19, 2022 |
|
Metabolic Engineering and Probiotics and Lactic Acid Bacteria
|
Oct 19, 2022 |
|
Technical Points of Recombinant Lactic Acid Bacteria
|
Oct 19, 2022 |
|
New Views on Recombinant Probiotics
|
Oct 19, 2022 |
|
What Is the Relationship Between AMPK Signaling Pathway and Probiotics?
|
Oct 19, 2022 |
|
Application of Probiotics in Various Parts
|
Oct 19, 2022 |
|
What is the Relationship Between Probiotic Feed and Performance Indicators of Animal Production?
|
Oct 19, 2022 |
|
Effects of Probiotics on Immunity and Rumen Function
|
Oct 19, 2022 |
|
Animal Feed Supplemented With Probiotics
|
Oct 19, 2022 |
|
More Beneficial Effects of Probiotics
|
Oct 19, 2022 |
|
What is the Role of Probiotics in Intestinal Diseases?
|
Oct 19, 2022 |
|
What Role Do Gut Microbes Play in the Treatment of Diabetes?
|
Oct 19, 2022 |
|
Gut Microbe and Celiac Disease
|
Oct 19, 2022 |
|
Gut Microbe and Non-Alcoholic Fatty Liver Disease
|
Oct 19, 2022 |
|
Beneficial Effects of Probiotics in Lowering Cholesterol, Treating Cancer, and Irritable Bowel Syndrome
|
Oct 19, 2022 |
|
Application of Probiotics in Obesity Management
|
Oct 19, 2022 |
|
Gut Microbe in Allergy and Autoimmune Disease
|
Oct 19, 2022 |
|
The Relationship Between Probiotics and Cardiovascular Diseases
|
Oct 19, 2022 |
|
Gut Microbe and GeneticNeurodevelopmental Disorders
|
Oct 19, 2022 |
|
Probiotics in Foodborne Disease Treatment
|
Oct 19, 2022 |
|
What are the Beneficial Effects of Probiotics?
|
Oct 19, 2022 |
|
What is the Relationship Between Probiotics and the Immune System?
|
Oct 19, 2022 |
|
What are the Effects of Probiotics on Human Health?
|
Oct 19, 2022 |
|
Mechanisms of Probiotics’ Benefits to Human and Animal
|
Oct 19, 2022 |
|
Comprehensive Knowledge of Prebiotics, Probiotics and Synbiotics
|
Oct 19, 2022 |
|
What are the Therapeutic Effects of Prebiotics?
|
Oct 19, 2022 |
|
Which Carbohydrates Belong to Prebiotics?
|
Oct 19, 2022 |
|
Prebiotics and Their Various Physiological Beneficial Effects
|
Oct 19, 2022 |
|
What is the Carbon Metabolism of Lactic Acid Bacteria?
|
Oct 19, 2022 |
|
Basic Information of Lactic Acid Bacteria as Probiotics
|
Oct 19, 2022 |
|
What are the Characteristics of Standard Probiotics?
|
Oct 18, 2022 |
|
What are the Applications of Probiotics
|
Oct 18, 2022 |
|
Introduction to Probiotics and Their Classification
|
Oct 18, 2022 |
|
A Brief Introduction to Non-IgG Antibody
|
Mar 28, 2022 |
|
Lipid-based Drug Delivery for Cacer Therapy
|
Mar 28, 2022 |
|
Introduction to Microfluidics
|
Oct 26, 2021 |
|
Webinar: Harnessing the Power of Bispecific Antibodies
|
Oct 19, 2021 |
|
Advances in RNA Sensing by the Immune System Separation of siRNA Unwanted Effects from RNA Interference-Ⅳ
|
Sep 27, 2021 |
|
Advances in RNA Sensing by the Immune System Separation of siRNA Unwanted Effects from RNA Interference-Ⅲ
|
Sep 27, 2021 |
|
Advances in RNA Sensing by the Immune System Separation of siRNA Unwanted Effects from RNA Interference-Ⅱ
|
Sep 27, 2021 |
|
Advances in RNA Sensing by the Immune System Separation of siRNA Unwanted Effects from RNA Interference-Ⅰ
|
Sep 27, 2021 |
|
Quantitative Analysis of RNA Modifications
|
Sep 27, 2021 |
|
Therapeutic Nucleic Acids
|
Sep 27, 2021 |
|
Gene Delivery Methods
|
Sep 27, 2021 |
|
Introduction to Gene Therapy
|
Sep 27, 2021 |
|
Ethical and Social Problems of Gene Therapy
|
Sep 27, 2021 |
|
Clinical Applications of Gene Therapy
|
Sep 27, 2021 |
|
Effector Functions Enhanced Antibodies
|
Sep 27, 2021 |
|
Progress in siRNA Delivery Using Multifunctional Nanoparticles-Ⅱ
|
Jul 26, 2021 |
|
Progress in siRNA Delivery Using Multifunctional Nanoparticle-Ⅰ
|
Jul 26, 2021 |
|
Stem Cells in A New Era of Cell based Therapies
|
Jul 26, 2021 |
|
Introduction to Live Biotherapeutics
|
May 31, 2021 |
|
Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer
|
May 31, 2021 |
|
Anti-Virus Biomolecular Discovery
|
May 13, 2021 |
|
Introduction to Oncolytic Virotherapy
|
Feb 02, 2021 |
|
Next Horizons-ADCs Beyond Oncology
|
Feb 02, 2021 |
|
Introduction to mRNA Vaccine
|
Dec 29, 2020 |
|
Antibody Drug Conjugates Targeting the Tumor Microenvironment
|
Dec 29, 2020 |
|
Targeting Drug Conjugates to the Tumor Microenvironment: Probody Drug Conjugates
|
Dec 29, 2020 |
|
Bispecific and Biparatopic Antibody Drug Conjugates
|
Dec 29, 2020 |
|
Genome Editing
|
Dec 25, 2020 |
|
Site-specific Antibody-drug Conjugates
|
Nov 16, 2020 |
|
NGS Introduction
|
Nov 12, 2020 |
|
Delivering More Payload - High DAR ADCs
|
Nov 04, 2020 |
|
Combining ADCs with Immuno Oncology
|
Sep 28, 2020 |
|
Next Generation Payloads for ADCs
|
Sep 28, 2020 |
|
Introduction Motivations for Next-Generation ADCs
|
Sep 28, 2020 |
|
SARS-CoV-2 Vaccine
|
Aug 20, 2020 |
|
Membane Protein Overview
|
Aug 06, 2020 |
|
Immunogenicity Overview of Therapeutic Biologics
|
Aug 06, 2020 |
|
Yeast Display Technology
|
Aug 06, 2020 |
|
Ribosome Display Technology
|
Aug 06, 2020 |
|
Recombinant Antibody Overview II
|
Aug 06, 2020 |
|
Recombinant Antibody Overview I
|
Aug 06, 2020 |
|
Recombinant Antibody Expression
|
Aug 06, 2020 |
|
Introduction of Recombinant Antibody
|
Aug 06, 2020 |
|
Development of Monoclonal Antibodies
|
Aug 06, 2020 |
|
De Novo Antibody Sequencing Service
|
Aug 06, 2020 |
|
Bacterial Display Technology
|
Aug 06, 2020 |
|
Antibody Library Screening
|
Aug 06, 2020 |
|
Antibody Humanization Service
|
Jul 31, 2020 |
|
Antibody Diversity—Gene Rearrangement
|
Jul 31, 2020 |
|
100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing
|
Jul 31, 2020 |
|
An Overview of Prostate Cancer
|
Jul 30, 2020 |
|
An Overview of Pancreatic Cancer
|
Jul 30, 2020 |
|
An Overview of Endometrial Cancer
|
Jul 30, 2020 |
|
An Overview of Thyroid Cancer
|
Jul 29, 2020 |
|
Virus-Based Gene Delivery System for CAR T Cell Engineering
|
Jul 29, 2020 |
|
Chimeric Antigen Receptor (CAR) Technology
|
Jul 29, 2020 |
|
Phage Display Technology
|
Jul 28, 2020 |
|
Antibody-based Cancer Therapies
|
Jul 28, 2020 |
|
Gene Delivery Systems for Gene Therapy
|
Jul 27, 2020 |
|
Oncolytic Virotherapy Basic Knowledge
|
Jul 27, 2020 |
|
Exosomes Biogenesis & Therapeutics
|
Jul 27, 2020 |
|
In Vitro Diagnostic (IVD) Antibody Development
|
Jun 09, 2020 |
|
SARS-CoV-2 Introduction
|
Jun 09, 2020 |
|
Vaccine Development and Manufacturing
|
Jun 03, 2020 |
|
Introduction to Nano Adjuvant
|
Jun 02, 2020 |
|
Introduction to HIV Vaccine
|
Jun 02, 2020 |
|
Introduction to HBV Vaccine
|
Jun 02, 2020 |
|
A Brief Introduction to Antibody-drug Conjugate
|
May 28, 2020 |
|
What is ADC ?
|
May 28, 2020 |